Loading…

Plasma omega-3 PUFA and white matter mediated executive decline in older adults

Cross-sectional studies have identified long chain omega-3 polyunsaturated fatty acids (eicosapentaenoic acid 20:5n-3 and docosahexaenoic acid 22:6n-3 (O3PUFA) in association with fewer white matter lesions and better executive function in older adults. We hypothesized that O3PUFA are associated wit...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in aging neuroscience 2013, Vol.5, p.92-92
Main Authors: Bowman, Gene L, Dodge, Hiroko H, Mattek, Nora, Barbey, Aron K, Silbert, Lisa C, Shinto, Lynne, Howieson, Diane B, Kaye, Jeffrey A, Quinn, Joseph F
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c556t-b7f5ce425568e80b7b3d7d45d1f8b0dd5e69be78c6d9c0f0737da2c248c98dfe3
cites
container_end_page 92
container_issue
container_start_page 92
container_title Frontiers in aging neuroscience
container_volume 5
creator Bowman, Gene L
Dodge, Hiroko H
Mattek, Nora
Barbey, Aron K
Silbert, Lisa C
Shinto, Lynne
Howieson, Diane B
Kaye, Jeffrey A
Quinn, Joseph F
description Cross-sectional studies have identified long chain omega-3 polyunsaturated fatty acids (eicosapentaenoic acid 20:5n-3 and docosahexaenoic acid 22:6n-3 (O3PUFA) in association with fewer white matter lesions and better executive function in older adults. We hypothesized that O3PUFA are associated with less executive decline over time and that total white matter hyperintensity volume (WMH) mediates this association. Eighty-six non-demented older adults were followed over 4 years after measurement of plasma O3PUFA with annual evaluations of cognitive function. A subset of these participants also had brain MRI of total WMH available to conduct a formal mediation analysis of a putative relationship between O3PUFA and cognitive function. Mean age at baseline was 86, 62% were female and 11% carried the APOE4 allele. Each 100 μg/ml increase in plasma O3PUFA associated with 4 s less change in executive decline per year of aging (p = 0.02, fully adjusted model). O3PUFA was not associated with verbal memory or global cognitive changes. The significance of the association between O3PUFA and better executive function was lost once WMH was added to the regression model. Executive decline with age appears to be a cognitive domain particularly sensitive to plasma O3PUFA in longitudinal examination. O3PUFA may modulate executive functioning by mechanisms underlying the development of WMH, a biologically plausible hypothesis that warrants further investigation.
doi_str_mv 10.3389/fnagi.2013.00092
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_e5fe87eca8fb49748f12dc1c66ce5b6e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_e5fe87eca8fb49748f12dc1c66ce5b6e</doaj_id><sourcerecordid>1490762684</sourcerecordid><originalsourceid>FETCH-LOGICAL-c556t-b7f5ce425568e80b7b3d7d45d1f8b0dd5e69be78c6d9c0f0737da2c248c98dfe3</originalsourceid><addsrcrecordid>eNpdkc1PFDEYhxujEbJy92SaePEyazv9nIsJISIkJHCQc9Np3y7dzEyx7aD-987uAgEPTb-e90nf_hD6SMmaMd19DZPdxHVLKFsTQrr2DTqmUrKGMynevlgfoZNStgtCGCNE6PfoqOVMdUqTY3R9M9gyWpxG2NiG4Zvb81NsJ49_38UKeLS1QsYj-GgreAx_wM01PgD24IY4AY4TToNfGOvnoZYP6F2wQ4GTx3mFbs-__zy7aK6uf1yenV41TghZm14F4YC3y0aDJr3qmVeeC0-D7on3AmTXg9JO-s6RQBRT3rau5dp12gdgK3R58Ppkt-Y-x9HmvybZaPYHKW-MzTW6AQyIAFqBszr0vFNcB9p6R52UDkQvd65vB9f93C-dOphqtsMr6eubKd6ZTXowTEumlrFCXx4FOf2aoVQzxuJgGOwEaS6G8o4o2UrNF_Tzf-g2zXlavsq0jNBOCC7oQpED5XIqJUN4fgwlZhe-2YdvduGbffhLyaeXTTwXPEXN_gGo3avs</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2301955451</pqid></control><display><type>article</type><title>Plasma omega-3 PUFA and white matter mediated executive decline in older adults</title><source>NCBI_PubMed Central(免费)</source><source>ProQuest - Publicly Available Content Database</source><creator>Bowman, Gene L ; Dodge, Hiroko H ; Mattek, Nora ; Barbey, Aron K ; Silbert, Lisa C ; Shinto, Lynne ; Howieson, Diane B ; Kaye, Jeffrey A ; Quinn, Joseph F</creator><creatorcontrib>Bowman, Gene L ; Dodge, Hiroko H ; Mattek, Nora ; Barbey, Aron K ; Silbert, Lisa C ; Shinto, Lynne ; Howieson, Diane B ; Kaye, Jeffrey A ; Quinn, Joseph F</creatorcontrib><description>Cross-sectional studies have identified long chain omega-3 polyunsaturated fatty acids (eicosapentaenoic acid 20:5n-3 and docosahexaenoic acid 22:6n-3 (O3PUFA) in association with fewer white matter lesions and better executive function in older adults. We hypothesized that O3PUFA are associated with less executive decline over time and that total white matter hyperintensity volume (WMH) mediates this association. Eighty-six non-demented older adults were followed over 4 years after measurement of plasma O3PUFA with annual evaluations of cognitive function. A subset of these participants also had brain MRI of total WMH available to conduct a formal mediation analysis of a putative relationship between O3PUFA and cognitive function. Mean age at baseline was 86, 62% were female and 11% carried the APOE4 allele. Each 100 μg/ml increase in plasma O3PUFA associated with 4 s less change in executive decline per year of aging (p = 0.02, fully adjusted model). O3PUFA was not associated with verbal memory or global cognitive changes. The significance of the association between O3PUFA and better executive function was lost once WMH was added to the regression model. Executive decline with age appears to be a cognitive domain particularly sensitive to plasma O3PUFA in longitudinal examination. O3PUFA may modulate executive functioning by mechanisms underlying the development of WMH, a biologically plausible hypothesis that warrants further investigation.</description><identifier>ISSN: 1663-4365</identifier><identifier>EISSN: 1663-4365</identifier><identifier>DOI: 10.3389/fnagi.2013.00092</identifier><identifier>PMID: 24379780</identifier><language>eng</language><publisher>Switzerland: Frontiers Research Foundation</publisher><subject>Age ; Aging ; Alzheimer's disease ; Apolipoprotein E4 ; Biomarkers ; Blood ; Cognition &amp; reasoning ; Cognitive ability ; cognitive decline ; Dementia ; Diabetes ; Docosahexaenoic acid ; Eicosapentaenoic acid ; Elderly ; Executive Function ; Fatty acids ; Hypertension ; Lipid Metabolism ; longitudinal data analysis ; Magnetic resonance imaging ; MRI ; Neurology ; Neuroscience ; Older people ; Plasma ; Polyunsaturated fatty acids ; Substantia alba</subject><ispartof>Frontiers in aging neuroscience, 2013, Vol.5, p.92-92</ispartof><rights>2013. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2013 Bowman, Dodge, Mattek, Barbey, Silbert, Shinto, Howieson, Kaye and Quinn. 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c556t-b7f5ce425568e80b7b3d7d45d1f8b0dd5e69be78c6d9c0f0737da2c248c98dfe3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2301955451/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2301955451?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,4024,25753,27923,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24379780$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bowman, Gene L</creatorcontrib><creatorcontrib>Dodge, Hiroko H</creatorcontrib><creatorcontrib>Mattek, Nora</creatorcontrib><creatorcontrib>Barbey, Aron K</creatorcontrib><creatorcontrib>Silbert, Lisa C</creatorcontrib><creatorcontrib>Shinto, Lynne</creatorcontrib><creatorcontrib>Howieson, Diane B</creatorcontrib><creatorcontrib>Kaye, Jeffrey A</creatorcontrib><creatorcontrib>Quinn, Joseph F</creatorcontrib><title>Plasma omega-3 PUFA and white matter mediated executive decline in older adults</title><title>Frontiers in aging neuroscience</title><addtitle>Front Aging Neurosci</addtitle><description>Cross-sectional studies have identified long chain omega-3 polyunsaturated fatty acids (eicosapentaenoic acid 20:5n-3 and docosahexaenoic acid 22:6n-3 (O3PUFA) in association with fewer white matter lesions and better executive function in older adults. We hypothesized that O3PUFA are associated with less executive decline over time and that total white matter hyperintensity volume (WMH) mediates this association. Eighty-six non-demented older adults were followed over 4 years after measurement of plasma O3PUFA with annual evaluations of cognitive function. A subset of these participants also had brain MRI of total WMH available to conduct a formal mediation analysis of a putative relationship between O3PUFA and cognitive function. Mean age at baseline was 86, 62% were female and 11% carried the APOE4 allele. Each 100 μg/ml increase in plasma O3PUFA associated with 4 s less change in executive decline per year of aging (p = 0.02, fully adjusted model). O3PUFA was not associated with verbal memory or global cognitive changes. The significance of the association between O3PUFA and better executive function was lost once WMH was added to the regression model. Executive decline with age appears to be a cognitive domain particularly sensitive to plasma O3PUFA in longitudinal examination. O3PUFA may modulate executive functioning by mechanisms underlying the development of WMH, a biologically plausible hypothesis that warrants further investigation.</description><subject>Age</subject><subject>Aging</subject><subject>Alzheimer's disease</subject><subject>Apolipoprotein E4</subject><subject>Biomarkers</subject><subject>Blood</subject><subject>Cognition &amp; reasoning</subject><subject>Cognitive ability</subject><subject>cognitive decline</subject><subject>Dementia</subject><subject>Diabetes</subject><subject>Docosahexaenoic acid</subject><subject>Eicosapentaenoic acid</subject><subject>Elderly</subject><subject>Executive Function</subject><subject>Fatty acids</subject><subject>Hypertension</subject><subject>Lipid Metabolism</subject><subject>longitudinal data analysis</subject><subject>Magnetic resonance imaging</subject><subject>MRI</subject><subject>Neurology</subject><subject>Neuroscience</subject><subject>Older people</subject><subject>Plasma</subject><subject>Polyunsaturated fatty acids</subject><subject>Substantia alba</subject><issn>1663-4365</issn><issn>1663-4365</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkc1PFDEYhxujEbJy92SaePEyazv9nIsJISIkJHCQc9Np3y7dzEyx7aD-987uAgEPTb-e90nf_hD6SMmaMd19DZPdxHVLKFsTQrr2DTqmUrKGMynevlgfoZNStgtCGCNE6PfoqOVMdUqTY3R9M9gyWpxG2NiG4Zvb81NsJ49_38UKeLS1QsYj-GgreAx_wM01PgD24IY4AY4TToNfGOvnoZYP6F2wQ4GTx3mFbs-__zy7aK6uf1yenV41TghZm14F4YC3y0aDJr3qmVeeC0-D7on3AmTXg9JO-s6RQBRT3rau5dp12gdgK3R58Ppkt-Y-x9HmvybZaPYHKW-MzTW6AQyIAFqBszr0vFNcB9p6R52UDkQvd65vB9f93C-dOphqtsMr6eubKd6ZTXowTEumlrFCXx4FOf2aoVQzxuJgGOwEaS6G8o4o2UrNF_Tzf-g2zXlavsq0jNBOCC7oQpED5XIqJUN4fgwlZhe-2YdvduGbffhLyaeXTTwXPEXN_gGo3avs</recordid><startdate>2013</startdate><enddate>2013</enddate><creator>Bowman, Gene L</creator><creator>Dodge, Hiroko H</creator><creator>Mattek, Nora</creator><creator>Barbey, Aron K</creator><creator>Silbert, Lisa C</creator><creator>Shinto, Lynne</creator><creator>Howieson, Diane B</creator><creator>Kaye, Jeffrey A</creator><creator>Quinn, Joseph F</creator><general>Frontiers Research Foundation</general><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>2013</creationdate><title>Plasma omega-3 PUFA and white matter mediated executive decline in older adults</title><author>Bowman, Gene L ; Dodge, Hiroko H ; Mattek, Nora ; Barbey, Aron K ; Silbert, Lisa C ; Shinto, Lynne ; Howieson, Diane B ; Kaye, Jeffrey A ; Quinn, Joseph F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c556t-b7f5ce425568e80b7b3d7d45d1f8b0dd5e69be78c6d9c0f0737da2c248c98dfe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Age</topic><topic>Aging</topic><topic>Alzheimer's disease</topic><topic>Apolipoprotein E4</topic><topic>Biomarkers</topic><topic>Blood</topic><topic>Cognition &amp; reasoning</topic><topic>Cognitive ability</topic><topic>cognitive decline</topic><topic>Dementia</topic><topic>Diabetes</topic><topic>Docosahexaenoic acid</topic><topic>Eicosapentaenoic acid</topic><topic>Elderly</topic><topic>Executive Function</topic><topic>Fatty acids</topic><topic>Hypertension</topic><topic>Lipid Metabolism</topic><topic>longitudinal data analysis</topic><topic>Magnetic resonance imaging</topic><topic>MRI</topic><topic>Neurology</topic><topic>Neuroscience</topic><topic>Older people</topic><topic>Plasma</topic><topic>Polyunsaturated fatty acids</topic><topic>Substantia alba</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bowman, Gene L</creatorcontrib><creatorcontrib>Dodge, Hiroko H</creatorcontrib><creatorcontrib>Mattek, Nora</creatorcontrib><creatorcontrib>Barbey, Aron K</creatorcontrib><creatorcontrib>Silbert, Lisa C</creatorcontrib><creatorcontrib>Shinto, Lynne</creatorcontrib><creatorcontrib>Howieson, Diane B</creatorcontrib><creatorcontrib>Kaye, Jeffrey A</creatorcontrib><creatorcontrib>Quinn, Joseph F</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Science Journals</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in aging neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bowman, Gene L</au><au>Dodge, Hiroko H</au><au>Mattek, Nora</au><au>Barbey, Aron K</au><au>Silbert, Lisa C</au><au>Shinto, Lynne</au><au>Howieson, Diane B</au><au>Kaye, Jeffrey A</au><au>Quinn, Joseph F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasma omega-3 PUFA and white matter mediated executive decline in older adults</atitle><jtitle>Frontiers in aging neuroscience</jtitle><addtitle>Front Aging Neurosci</addtitle><date>2013</date><risdate>2013</risdate><volume>5</volume><spage>92</spage><epage>92</epage><pages>92-92</pages><issn>1663-4365</issn><eissn>1663-4365</eissn><abstract>Cross-sectional studies have identified long chain omega-3 polyunsaturated fatty acids (eicosapentaenoic acid 20:5n-3 and docosahexaenoic acid 22:6n-3 (O3PUFA) in association with fewer white matter lesions and better executive function in older adults. We hypothesized that O3PUFA are associated with less executive decline over time and that total white matter hyperintensity volume (WMH) mediates this association. Eighty-six non-demented older adults were followed over 4 years after measurement of plasma O3PUFA with annual evaluations of cognitive function. A subset of these participants also had brain MRI of total WMH available to conduct a formal mediation analysis of a putative relationship between O3PUFA and cognitive function. Mean age at baseline was 86, 62% were female and 11% carried the APOE4 allele. Each 100 μg/ml increase in plasma O3PUFA associated with 4 s less change in executive decline per year of aging (p = 0.02, fully adjusted model). O3PUFA was not associated with verbal memory or global cognitive changes. The significance of the association between O3PUFA and better executive function was lost once WMH was added to the regression model. Executive decline with age appears to be a cognitive domain particularly sensitive to plasma O3PUFA in longitudinal examination. O3PUFA may modulate executive functioning by mechanisms underlying the development of WMH, a biologically plausible hypothesis that warrants further investigation.</abstract><cop>Switzerland</cop><pub>Frontiers Research Foundation</pub><pmid>24379780</pmid><doi>10.3389/fnagi.2013.00092</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1663-4365
ispartof Frontiers in aging neuroscience, 2013, Vol.5, p.92-92
issn 1663-4365
1663-4365
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_e5fe87eca8fb49748f12dc1c66ce5b6e
source NCBI_PubMed Central(免费); ProQuest - Publicly Available Content Database
subjects Age
Aging
Alzheimer's disease
Apolipoprotein E4
Biomarkers
Blood
Cognition & reasoning
Cognitive ability
cognitive decline
Dementia
Diabetes
Docosahexaenoic acid
Eicosapentaenoic acid
Elderly
Executive Function
Fatty acids
Hypertension
Lipid Metabolism
longitudinal data analysis
Magnetic resonance imaging
MRI
Neurology
Neuroscience
Older people
Plasma
Polyunsaturated fatty acids
Substantia alba
title Plasma omega-3 PUFA and white matter mediated executive decline in older adults
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T06%3A13%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasma%20omega-3%20PUFA%20and%20white%20matter%20mediated%20executive%20decline%20in%20older%20adults&rft.jtitle=Frontiers%20in%20aging%20neuroscience&rft.au=Bowman,%20Gene%20L&rft.date=2013&rft.volume=5&rft.spage=92&rft.epage=92&rft.pages=92-92&rft.issn=1663-4365&rft.eissn=1663-4365&rft_id=info:doi/10.3389/fnagi.2013.00092&rft_dat=%3Cproquest_doaj_%3E1490762684%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c556t-b7f5ce425568e80b7b3d7d45d1f8b0dd5e69be78c6d9c0f0737da2c248c98dfe3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2301955451&rft_id=info:pmid/24379780&rfr_iscdi=true